Specimen Collection, Transport, and Primary Processing in Microbiology

An organism is recovered when the specimen is taken from the true site of infection, at a time when the organism is present, in a volume the method can detect, and delivered under conditions that keep the pathogen alive while holding contaminating flora in check. Every later step, from the Gram stain to the final susceptibility report, inherits whatever the collection and transport steps preserved or destroyed.¹

Acid-fast and modified acid-fast staining are covered with mycobacteriology, and KOH, calcofluor-white, trichrome, and Giemsa preparations are covered with mycology and parasitology.

Collection

Bacterial specimens should be collected before antimicrobial therapy begins, because even a single dose can suppress growth in culture. Viral specimens give the highest yield during the acute phase of illness, when shedding peaks. Volume matters as much as timing: most methods have a minimum volume below which sensitivity falls sharply, so an underfilled specimen is referred back for recollection, or the ordering clinician is asked to rank the requested tests when the volume cannot support all of them.¹

Collect from the actual site of infection with as little contact with adjacent tissue and secretions as the site allows. Every specimen except stool goes into a sterile container. The label must carry the patient’s name or unique identifier and the specimen source.² Laboratory procedure also requires the date and time of collection on the label, because collection time anchors every transport limit.^1,6 The source is part of the result: deciding whether an isolate is a pathogen or a contaminant depends on knowing which body site, with which resident flora, the specimen came from. Urine container, labeling, and preservation practice is covered in Specimen Handling and Acceptability.

Swabs. A swab traps much of the collected material in its own fibers, so it delivers less specimen than an aspirate or a tissue sample. Swabs are reserved for sites no better device can reach, such as the throat, the nasopharynx, or the cervix, and they are a poor choice for anaerobes, mycobacteria, and fungi, which should arrive as aspirated fluid or tissue whenever the site permits.¹

Swab tip and shaft materials decide what the swab can recover, because several materials are toxic to the target organism or inhibit the amplification enzymes a molecular assay depends on:

The safe default for gonococcal culture and for any nucleic acid amplification test (NAAT) is a plastic-shafted Dacron, rayon, or nylon swab,^3,6 and any other combination of fiber, shaft, and transport should be validated against the specific assay before use. FDA-cleared molecular assays list their acceptable collection devices in the manufacturer’s instructions, and those instructions control.³

Transport

Transport temperature follows the organisms expected at the collection site. Sterile-site fluids, blood, and gonococcal specimens carry refrigeration-sensitive pathogens, so they stay at room temperature when delivery is delayed. Urine, respiratory secretions, and stool carry heavy resident flora that overgrows a pathogen at room temperature within hours, so refrigeration protects those specimens during delay.^1,6

Cerebrospinal fluid for culture is never refrigerated. Specimens collected into an FDA-cleared molecular collection kit follow that kit’s storage and transport instructions, which commonly permit room temperature; the refrigeration rule above applies to culture specimens and viral transport medium.^3,6

Molecular specimens. Nucleic acid testing does not require a viable organism, because lysed and dead cells still carry amplifiable target. It does require intact nucleic acid, and DNA and especially RNA degrade quickly once cells lyse, so molecular specimens travel promptly in a stabilizing medium, and RNA targets demand RNase-free handling of tubes, reagents, and work surfaces. Amplification can detect a single template molecule, which makes contamination control as critical as degradation control: a trace of carried-over product or of a previous specimen produces a false positive that no downstream step can identify.¹

Sensitivity this high also changes interpretation. A positive molecular result can represent colonization, resolved infection, or an organism burden below clinical significance, so quantity and clinical context weigh alongside the detection. A primer set built against one strain can miss a divergent variant of the same species. Collection timing must also match where the organism is in its course: in typhoid fever, blood culture is the preferred early specimen even though a single set detects only about half of cases, and stool culture is usually still negative during the first week of illness.⁷

Extraction of microbial nucleic acid follows the same principles as human-cell extraction, with four organism-specific complications:¹

1. Lysis resistance varies with cell-wall architecture. Mycobacteria and fungi have thick, lipid-rich walls that need aggressive mechanical or chemical disruption, gram-positive walls resist lysis more than gram-negative walls, and Mycoplasma species, which have no cell wall, lyse so easily that target can be lost to rough handling before extraction begins.
2. Concentration must match the reaction volume. Milliliter-scale fluids are centrifuged down to the microliter volumes that extraction and amplification actually use.
3. Amplification inhibitors must be removed. Hemoglobin and its breakdown products inhibit polymerase in whole blood, acidic polysaccharides do the same in sputum, and urine carries urea, crystals, and hemoglobin as its own inhibitors.
4. RNA work adds RNase control at every step.

Specimen type predicts the preparation. Whole blood is processed to concentrate leukocytes, which harbor intracellular organisms and cell-associated viruses; density-gradient separation is the classical method, and automated extraction platforms that remove hemoglobin now handle most routine work. Serum and plasma are the preferred sources for cell-free viral nucleic acid. Sputum needs inhibitor removal before extraction, and urine and CSF are centrifuged to pellet organisms.¹

Shipping to a reference laboratory. Referred specimens and cultures ship under the dangerous-goods rules as triple packages: a sealed primary receptacle; a leakproof secondary container with absorbent material sufficient to soak up the entire contents, with multiple primary tubes individually wrapped or separated; and a rigid outer shipping container. For Category B infectious substances (UN 3373) shipped by air, each primary receptacle is limited to 1 L and the outer package to 4 L. Category A packages carry stricter limits, 50 mL or 50 g per package on a passenger aircraft and 4 L or 4 kg on a cargo aircraft, and add requirements such as an itemized contents list between the secondary and outer layers and taped, positively sealed closures.⁸

Receipt, prioritization, and rejection

Specimens are triaged on receipt. Invasive, irreplaceable, and rapidly deteriorating specimens, including CSF, other sterile body fluids, tissue, and surgical specimens, are processed first, ahead of routine swabs and stable specimens. An irreplaceable specimen is not discarded over a labeling or collection defect; the laboratory contacts the ordering clinician, documents the problem and its resolution, and processes the specimen when the clinician confirms it should proceed. A compromised specimen that can be recollected is rejected with a request for a new one.¹

Each laboratory director establishes the site’s written acceptability and rejection criteria under CLIA.² The following rejections are standard across clinical microbiology laboratories:^1,6

Additional specimen types are rejected specifically for anaerobic culture because they are routinely contaminated with anaerobic resident flora that culture cannot distinguish from an anaerobic pathogen: gastric washings; urine other than a suprapubic aspirate; stool, except when anaerobic culture is specifically requested for outbreak typing or a suspected foodborne pathogen, since routine Clostridioides difficile diagnosis uses toxin and nucleic acid testing instead of culture; oropharyngeal specimens other than deep tissue collected at surgery; sputum; swabs of ileostomy or colostomy sites; and superficial skin specimens.¹

Worker protection

Every specimen is treated as infectious, because collection, transport, and processing inactivate organisms at different points, and a specimen that looks finished may still contain viable pathogen. Growing the organism in culture is the most exposure-prone step of traditional workup, which is why molecular methods that test inactivated specimens directly carry an inherent safety advantage.¹ Standard Precautions apply to blood; to all body fluids, secretions, and excretions except sweat, regardless of visible blood; to nonintact skin; and to mucous membranes. CDC created Standard Precautions in 1996 by unifying Universal Precautions, which addressed bloodborne pathogens, with Body Substance Isolation, which addressed organisms on moist body surfaces; the 2007 isolation-precautions guideline carries the current statement.⁹ OSHA’s bloodborne pathogens standard remains the enforceable federal regulation behind this practice and still uses the term universal precautions.¹⁰ Under CLIA the laboratory director may assign safety duties to other staff but keeps the accountability for a safe laboratory environment.² A specimen suspected of containing a select agent, such as variola virus, is handled only within the containment the agent requires and is referred to the public health laboratory network; maximum-containment work is restricted to biosafety level 4 facilities.¹¹

Biological safety cabinet. The Class II Type A2 cabinet is the routine containment device of clinical microbiology, and it protects three things at once. An inward air barrier at the sash, with a minimum face velocity of 100 linear feet per minute, sweeps room air into the cabinet and keeps aerosols out of the worker’s breathing zone. HEPA-filtered downflow air bathes the work surface and protects the specimen from room contamination. Exhaust air passes through a second HEPA filter before it returns to the room or leaves through a canopy connection; recirculation to the room is acceptable only when no volatile toxic chemicals are used in the cabinet, because HEPA filters trap particulates and let vapors through. Work with volatile or flammable chemicals belongs in a chemical fume hood.¹¹

Containment depends on work practices as much as on the cabinet. Arms move in and out slowly so the air curtain is not disrupted. The front and rear grilles stay clear of equipment, paper, and elbows. Work is performed at least 4 inches inside the sash. The work surface is decontaminated before and after use and immediately after any spill, and the cabinet runs for several minutes before and after work to purge airborne contaminants. Under the laboratory’s accreditation requirements, each cabinet is certified to the NSF/ANSI 49 standard at installation, at least annually, after relocation, and after filter replacement or internal repair.¹¹

Any specimen or culture that may contain Mycobacterium tuberculosis, a mold, or a select agent is opened and subcultured inside a certified cabinet. Every aerosol-generating manipulation, including grinding tissue, vortexing, sonicating, and opening lyophilized cultures, is performed inside the cabinet regardless of the organism suspected, because the manipulation itself creates the exposure.¹¹

Personal protective equipment and biosafety levels. Gloves, a fluid-resistant laboratory coat or gown, and face or eye protection accompany any procedure that could splash or aerosolize material. When an aerosol-generating procedure on a specimen likely to contain M. tuberculosis must be performed outside a biological safety cabinet, a fit-tested N95 respirator is the minimum respiratory protection, a powered air-purifying respirator (PAPR) is a higher level of protection selected by risk assessment, and any respirator use requires the full OSHA respiratory protection program of medical evaluation, fit testing, and training.^10,12 A respirator is the last control, reached only after an aerosol has already escaped cabinet containment. Routine bacteriology is performed at biosafety level 2 (BSL-2). For M. tuberculosis, clinical specimens are processed at BSL-2 with every manipulation inside a biological safety cabinet, and propagation or manipulation of cultures moves to BSL-3, which adds directional inward airflow and controlled laboratory access.¹¹

Direct examination

The direct smear gives the clinician same-day guidance and gives the laboratory a quality check on the specimen and a preview of how much workup a recovered organism deserves. An organism seen in abundance alongside many white blood cells earns more identification effort than the same organism seen sparsely with no inflammatory response, and the same organism recovered from repeated specimens from one patient raises confidence that the isolate is significant.¹

Gram stain. An aliquot of the most purulent or bloody portion of the specimen is spread to give a thick and a thin area, air-dried, and fixed. Methanol fixation is preferred because it preserves cell morphology and avoids the background distortion of heat; gentle heat remains an acceptable alternative. Sterile fluids such as CSF are cytocentrifuged first, which increases the yield of visible organisms by up to about 100-fold and makes an otherwise unreadable organism burden detectable.^1,13 The smear is stained with crystal violet, Gram’s iodine, a decolorizer, and safranin. Gram-positive walls hold the purple crystal violet-iodine complex through decolorization; gram-negative walls decolorize and take the safranin counterstain, pink to red.

Examination starts at low power, which catches large structures such as nematode larvae, Curschmann spirals, sulfur granules, microcolonies, and fungal forms, then moves to oil immersion at 1000x to characterize bacteria. Roughly 10⁵ organisms per milliliter must be present for about one organism to appear per oil-immersion field, so a negative smear never excludes a low-burden infection.¹

The report describes size, shape, arrangement, and Gram reaction as specifically as the smear allows; “gram-positive cocci in pairs, morphology consistent with S. pneumoniae” guides therapy far better than “gram-positive cocci.” White blood cells and squamous epithelial cells are quantified, because they measure inflammation and, for respiratory specimens, oropharyngeal contamination; the numeric adequacy thresholds for sputum are applied with the respiratory workup. Intracellular organisms are noted. Comparing the smear with the eventual culture checks both: organisms seen on the smear that fail to grow point to an organism needing special media or to a false-positive smear from contaminated reagents or misreading, and heavy growth of one organism missing from the smear may prompt added media on the next specimen, such as a chocolate plate to recover Haemophilus seen as gram-negative coccobacilli that blood agar alone would miss.¹

Acridine orange. Acridine orange is a fluorochrome that intercalates into nucleic acid. In a smear buffered to about pH 4, bacterial and fungal nucleic acid fluoresces bright orange under blue or ultraviolet excitation while human cell material fluoresces green; the contrast is a property of the acidic staining conditions and is lost near neutral pH. The smear is prepared and fixed as for a Gram stain, flooded with working solution, rinsed, and read promptly on a fluorescence microscope fitted with the correct excitation and barrier filters, because the fluorescence fades.¹

The stain detects roughly 10⁴ organisms per milliliter, below the Gram stain’s threshold, which sets its three classic uses: re-examining a Gram-negative smear from a sterile site when infection is still suspected, screening blood culture broth for early growth before turbidity appears, and screening cell cultures for Mycoplasma, which lacks a cell wall and stains poorly by Gram. Its limits match its chemistry: it marks all organisms alike without a Gram reaction, it stains nucleic acid whether the organism is alive or dead, background debris can fluoresce, and a positive result must be followed by a Gram stain or culture before it can guide therapy. It also requires a fluorescence microscope.¹

Media selection and inoculation

Media give the pathogens expected at a site their optimal growth conditions and select them out of the resident flora:¹

Inoculation. When one specimen feeds several media, plates are inoculated before broth, and less selective media before more selective ones, so the richest media receive specimen before the inoculum is depleted. Each plate is then streaked for isolation: the specimen is applied to one edge, and the loop, sterilized or turned between passes, drags a diminishing number of organisms through three or four successive quadrants until single cells are deposited far enough apart to grow into separated colonies. Isolated colonies are the requirement for every downstream identification and susceptibility method. For specimens where the number of organisms changes the interpretation, a calibrated loop delivering a fixed volume, commonly 0.001 or 0.01 mL, spreads the specimen over the whole plate; a 0.001 mL loop multiplies the colony count by 1,000 and a 0.01 mL loop by 100 to give colony-forming units (CFU) per milliliter.¹

Worked example. A body fluid plated with a 0.001 mL calibrated loop grows 78 colonies after overnight incubation. Each colony represents one organism in the 0.001 mL the loop delivered, so the count is 78 × 1,000 = 78,000 CFU/mL.

Incubation

Routine bacterial cultures incubate at 35 ± 2 °C. An atmosphere of 5%-10% CO₂ is essential or stimulatory for N. gonorrhoeae, H. influenzae, and S. pneumoniae and should be used whenever feasible.^1,3 Selective and differential enteric media such as MacConkey, xylose-lysine-deoxycholate, and Hektoen enteric agar incubate in ambient air, because added CO₂ acidifies the medium, distorting the pH-indicator reactions the differentiation depends on, and can reduce recovery of some gram-negative bacilli.^1,14

Anaerobic culture requires rapid transfer to an oxygen-free environment. The routine method is a sealed jar or pouch with a sachet that activates on exposure to air and absorbs oxygen while generating CO₂; current sachet systems require no added water or catalyst, while older generator systems removed residual oxygen by reacting it with hydrogen over a palladium-coated alumina catalyst. High-volume laboratories use an anaerobic chamber, an airtight enclosure filled with an oxygen-free nitrogen-hydrogen-CO₂ mixture, entered through a gas-interchange lock, with glove or sleeve ports and an internal incubator; palladium catalysis with the ambient hydrogen maintains anaerobiosis. Anaerobe recovery is comparable across these systems, which differ in cost, throughput, and convenience.¹

Routine plates are examined at 18-24 hours and generally held 48 hours; broths are held an additional 24-48 hours beyond their plates. Anaerobic plates are first opened at 48 hours, because the colonies grow slowly and premature oxygen exposure costs recovery, and are held at least 5 days. Organisms that need longer incubation are held individually.¹

Reporting cadence

A preliminary report issues at the first examination and is updated as identification and susceptibility information accumulates, and a final report issues when all work is complete. Certain findings leave the routine cycle entirely: a positive blood or CSF Gram stain, and isolation of an organism that triggers infection-control action, are communicated to the treating clinician as soon as they are known, matching the CLIA requirement that alert values be reported immediately.²

References

1. Tille PM. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2021.
2. Laboratory requirements. 42 CFR part 493, §493.1242, §493.1291, §493.1445 (2026). Accessed August 28, 2026.
3. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWR Recomm Rep. 2014;63(RR-2):1-19. Accessed August 28, 2026.
4. Lauer BA, Masters HB. Toxic effect of calcium alginate swabs on Neisseria gonorrhoeae. J Clin Microbiol. 1988;26(1):54-56. doi:10.1128/jcm.26.1.54-56.1988
5. Wadowsky RM, Laus S, Libert T, States SJ, Ehrlich GD. Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab. J Clin Microbiol. 1994;32(4):1054-1057. doi:10.1128/jcm.32.4.1054-1057.1994
6. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104
7. Centers for Disease Control and Prevention. Typhoid and paratyphoid fever. CDC Yellow Book 2026. Accessed August 28, 2026.
8. Transportation: hazardous materials regulations. 49 CFR §172.101, §173.27, §173.196, §173.199 (2026). Accessed August 28, 2026.
9. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 suppl 2):S65-S164. doi:10.1016/j.ajic.2007.10.007
10. Occupational safety and health standards: bloodborne pathogens; respiratory protection. 29 CFR §1910.1030, §1910.134 (2026). Accessed August 28, 2026.
11. Centers for Disease Control and Prevention, National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. 6th ed. US Department of Health and Human Services; 2020. Accessed August 28, 2026.
12. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1-141. Accessed August 28, 2026.
13. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. doi:10.1086/425368
14. Hasan MR, Suleiman M, Ilagan E, et al. Growth of clinically important gram-negative bacteria on MacConkey agar under aerobic versus CO₂-enriched environment. J Clin Microbiol. 2019;57(12):e01441-19. doi:10.1128/JCM.01441-19